Met Life Investment Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Met Life Investment Management, LLC

$18.1 Billion
Q1 2025

A detailed history of Met Life Investment Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 5,461 shares of RARE stock, worth $194,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,461

Previous 5,473 0.22%

Holding current value

$194,739

Previous $230,000 14.35%

% of portfolio

0.0%

Previous 0.0%

69 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$36.21 - $45.78 $434 - $549	-12 Reduced 0.22%	5,461 $197,000
Q4 2024 Feb 13, 2025	SELL	$42.07 - $57.72 $8,750 - $12,005	-208 Reduced 3.66%	5,473 $230,000
Q3 2024 Nov 13, 2024	BUY	$40.21 - $59.36 $2,935 - $4,333	73 Added 1.3%	5,681 $315,000
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $31,021 - $42,784	829 Added 17.35%	5,608 $230,000
Q1 2024 May 14, 2024	BUY	$43.02 - $53.69 $205,592 - $256,584	4,779 New	4,779 $223,000
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $19,291 - $29,907	608 Added 14.63%	4,764 $227,000
Q3 2023 May 09, 2024	BUY	$34.92 - $46.66 $24,444 - $32,661	700 Added 20.25%	4,156 $148,000
Q3 2023 Apr 29, 2024	BUY	$34.92 - $46.66 $69 - $93	2 Added 0.05%	4,156 $148,000
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $69 - $93	2 Added 0.05%	4,156 $148,000
Q2 2023 Apr 29, 2024	BUY	$37.35 - $52.15 $155,151 - $216,631	4,154 New	4,154 $191,000
Q2 2023 Aug 10, 2023	BUY	$37.35 - $52.15 $26,070 - $36,400	698 Added 20.2%	4,154 $191,000
Q1 2023 May 09, 2024	BUY	$36.99 - $48.71 $127,837 - $168,341	3,456 New	3,456 $139 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $295 - $389	8 Added 0.23%	3,456 $138,000
Q4 2022 May 10, 2024	SELL	$33.72 - $46.33 $2,765 - $3,799	-82 Reduced 2.32%	3,448 $159,000
Q4 2022 Jun 14, 2023	SELL	$33.72 - $46.33 $269 - $370	-8 Reduced 0.23%	3,448 $159,000
Q4 2022 Mar 22, 2023	SELL	$33.72 - $46.33 $2,765 - $3,799	-82 Reduced 2.32%	3,448 $159,000
Q4 2022 Feb 15, 2023	SELL	$33.72 - $46.33 $2,765 - $3,799	-82 Reduced 2.32%	3,448 $159,000
Q3 2022 May 10, 2024	SELL	$39.96 - $66.14 $159 - $264	-4 Reduced 0.11%	3,530 $146,000
Q3 2022 Jun 14, 2023	BUY	$39.96 - $66.14 $2,957 - $4,894	74 Added 2.14%	3,530 $146,000
Q3 2022 Mar 22, 2023	SELL	$39.96 - $66.14 $159 - $264	-4 Reduced 0.11%	3,530 $146,000
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $159 - $264	-4 Reduced 0.11%	3,530 $146,000
Q2 2022 May 10, 2024	BUY	$45.8 - $85.4 $3,068 - $5,721	67 Added 1.93%	3,534 $210,000
Q2 2022 Jun 20, 2023	BUY	$45.8 - $85.4 $3,572 - $6,661	78 Added 2.26%	3,534 $210,000
Q2 2022 Mar 22, 2023	BUY	$45.8 - $85.4 $3,068 - $5,721	67 Added 1.93%	3,534 $210,000
Q2 2022 Aug 11, 2022	BUY	$45.8 - $85.4 $3,068 - $5,721	67 Added 1.93%	3,534 $211,000
Q1 2022 May 10, 2024	BUY	$62.2 - $84.4 $215,647 - $292,614	3,467 New	3,467 $251,000
Q1 2022 Jun 20, 2023	BUY	$62.2 - $84.4 $684 - $928	11 Added 0.32%	3,467 $251,000
Q1 2022 Mar 22, 2023	BUY	$62.2 - $84.4 $195,245 - $264,931	3,139 Added 957.01%	3,467 $251,000
Q1 2022 May 12, 2022	BUY	$62.2 - $84.4 $215,647 - $292,614	3,467 New	3,467 $252,000
Q4 2021 Feb 15, 2022	SELL	$73.71 - $87.86 $24,176 - $28,818	-328 Closed	0 $0
Q3 2021 Mar 22, 2023	SELL	$77.92 - $102.4 $1.81 Million - $2.38 Million	-23,222 Reduced 98.61%	328 $29,000
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $25,557 - $33,587	328 New	328 $30,000
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $2.17 Million - $2.72 Million	-23,550 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$106.9 - $167.73 $2.01 Million - $3.15 Million	18,771 Added 392.78%	23,550 $2.68 Million
Q1 2021 Jun 26, 2023	BUY	$106.9 - $167.73 $2.15 Million - $3.37 Million	20,094 Added 581.42%	23,550 $2.68 Billion
Q1 2021 Mar 22, 2023	SELL	$106.9 - $167.73 $142,390 - $223,416	-1,332 Reduced 5.35%	23,550 $2.68 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $142,390 - $223,416	-1,332 Reduced 5.35%	23,550 $2.68 Million
Q4 2020 May 24, 2024	BUY	$84.4 - $177.39 $83,893 - $176,325	994 Added 4.16%	24,882 $3.44 Million
Q4 2020 Jun 22, 2023	BUY	$84.4 - $177.39 $1.81 Million - $3.8 Million	21,426 Added 619.97%	24,882 $3.44 Million
Q4 2020 Mar 22, 2023	BUY	$84.4 - $177.39 $83,893 - $176,325	994 Added 4.16%	24,882 $3.44 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $83,893 - $176,325	994 Added 4.16%	24,882 $3.44 Million
Q3 2020 May 24, 2024	SELL	$72.98 - $90.0 $78,015 - $96,210	-1,069 Reduced 4.28%	23,888 $1.96 Billion
Q3 2020 Jun 26, 2023	BUY	$72.98 - $90.0 $1.49 Million - $1.84 Million	20,432 Added 591.2%	23,888 $1.96 Million
Q3 2020 Mar 22, 2023	SELL	$72.98 - $90.0 $78,015 - $96,210	-1,069 Reduced 4.28%	23,888 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $78,015 - $96,210	-1,069 Reduced 4.28%	23,888 $1.96 Million
Q2 2020 May 24, 2024	BUY	$46.91 - $78.22 $946,549 - $1.58 Million	20,178 Added 422.22%	24,957 $1.95 Billion
Q2 2020 Jun 26, 2023	BUY	$46.91 - $78.22 $1.01 Million - $1.68 Million	21,501 Added 622.14%	24,957 $1.95 Million
Q2 2020 Mar 22, 2023	BUY	$46.91 - $78.22 $98,604 - $164,418	2,102 Added 9.2%	24,957 $1.95 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $98,604 - $164,418	2,102 Added 9.2%	24,957 $1.95 Million
Q1 2020 Jul 12, 2023	BUY	$33.8 - $62.9 $655,686 - $1.22 Million	19,399 Added 561.31%	22,855 $1.02 Million
Q1 2020 Mar 22, 2023	SELL	$33.8 - $62.9 $54,316 - $101,080	-1,607 Reduced 6.57%	22,855 $1.02 Million
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $54,316 - $101,080	-1,607 Reduced 6.57%	22,855 $1.02 Million
Q4 2019 Jul 12, 2023	BUY	$36.08 - $45.83 $757,896 - $962,704	21,006 Added 607.81%	24,462 $1.04 Million
Q3 2019 Jul 12, 2023	BUY	$42.5 - $63.11 $892,755 - $1.33 Million	21,006 Added 607.81%	24,462 $1.05 Million
Q3 2019 Mar 22, 2023	BUY	$42.5 - $63.11 $92,055 - $136,696	2,166 Added 9.71%	24,462 $1.05 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $92,055 - $136,696	2,166 Added 9.71%	24,462 $1.05 Million
Q2 2019 Jul 12, 2023	BUY	$54.93 - $74.36 $1.15 Million - $1.56 Million	21,006 Added 607.81%	24,462 $1.55 Million
Q1 2019 Jul 13, 2023	BUY	$39.87 - $69.36 $751,150 - $1.31 Million	18,840 Added 545.14%	22,296 $1.55 Million
Q1 2019 Mar 22, 2023	BUY	$39.87 - $69.36 $82,491 - $143,505	2,069 Added 10.23%	22,296 $1.55 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $82,491 - $143,505	2,069 Added 10.23%	22,296 $1.55 Million
Q4 2018 Jul 13, 2023	BUY	$38.89 - $77.3 $652,224 - $1.3 Million	16,771 Added 485.27%	20,227 $879,000
Q4 2018 Mar 22, 2023	SELL	$38.89 - $77.3 $461,274 - $916,855	-11,861 Reduced 36.96%	20,227 $879,000
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $461,274 - $916,855	-11,861 Reduced 36.96%	20,227 $879,000
Q3 2018 Jul 13, 2023	BUY	$71.81 - $90.15 $1.2 Million - $1.51 Million	16,771 Added 485.27%	20,227 $1.54 Million
Q3 2018 Mar 22, 2023	BUY	$71.81 - $90.15 $2.06 Million - $2.58 Million	28,640 Added 830.63%	32,088 $2.45 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $759,965 - $954,057	10,583 Added 49.21%	32,088 $2.45 Million
Q2 2018 Aug 15, 2018	BUY	$48.54 - $85.31 $67,130 - $117,983	1,383 Added 6.87%	21,505 $1.65 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $80,104 - $105,745	1,807 Added 9.87%	20,122 $1.03 Million
Q4 2017 Feb 15, 2018	BUY	$43.54 - $57.32 $797,435 - $1.05 Million	18,315	18,315 $849,000

Others Institutions Holding RARE

# of Institutions

336

Shares Held

88.9M

Call Options Held

1.08M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.5B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History